| A Biological Atlas of Severe Obesity (Biological Tissue Collection) (NCT01129297) | University Hospital, Lille | 2006-06-13 |
| Switch From Premixed Human Insulin to Biphasic Insulin Aspart in the Netherlands (NCT01536626) | Novo Nordisk A/S | 2006-06-09 |
| Insulin Profile of Biphasic Insulin Aspart 70 to That of Biphasic Insulin Aspart 30 in Healthy Volunteers (NCT01538511) | Novo Nordisk A/S | 2006-06-05 |
| Improving Adherence to Prescribing Guidelines for Cholesterol Lowering in Hospitalized Diabetic Patients (NCT01113099) | Washington University School of Medicine | 2006-06-01 |
| Metabolic Profile and Anthropometric Changes in Schizophrenia (NCT00534183) | Central Institute of Psychiatry, Ranchi, India | 2006-06-01 |
| Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise (NCT00316082) | AstraZeneca | 2006-06-01 |
| Impact of Continuing Medical Education (CME) Insulin Program (NCT00824603) | HealthPartners Institute | 2006-06-01 |
| Can Group Visits Improve Outcomes of Veterans With Diabetes (NCT00286741) | US Department of Veterans Affairs | 2006-06-01 |
| Comparison of NovoFine® Needles (4 mm vs. 6 mm) (NCT00343343) | Novo Nordisk A/S | 2006-06-01 |
| Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Healthy Volunteers (NCT01489644) | Novo Nordisk A/S | 2006-06-01 |
| Single Dose Pharmacokinetics of Repaglinide, Metformin and Combination Tablet in Fed Healthy Volunteers (NCT01490658) | Novo Nordisk A/S | 2006-06-01 |
| Noninvasive Blood Glucose Monitoring Using Otoacoustic Emissions (NCT01073137) | Portland VA Medical Center | 2006-06-01 |
| Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00333151) | Novo Nordisk A/S | 2006-05-01 |
| Hypertension Related Damage to the Microcirculation in South Asian: Emergence, Predictive Power and Reversibility (NCT00331370) | Aga Khan University | 2006-05-01 |
| Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes (NCT01545791) | Novo Nordisk A/S | 2006-05-01 |
| Laparoscopic Adjustable Gastric Banding With Truncal Vagotomy (NCT00329862) | Central Carolina Surgery, PA | 2006-05-01 |
| Safety and Efficacy of Inhaled Insulin in Type 1 Diabetes (NCT00322257) | Novo Nordisk A/S | 2006-05-01 |
| A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise (NCT00327015) | AstraZeneca | 2006-05-01 |
| Effect of Liraglutide on Gastrointestinal Absorption of Several Drugs and Potential Influence of Liraglutide on Intragastric pH (NCT01518166) | Novo Nordisk A/S | 2006-05-01 |
| Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00331851) | Novo Nordisk A/S | 2006-05-01 |
| Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00318422) | Novo Nordisk A/S | 2006-05-01 |
| Bioequivalence of Two Insulatard® Formulations in Healthy Subjects (NCT01486901) | Novo Nordisk A/S | 2006-05-01 |
| Bioequivalence of Two Mixtard® 30 Formulations in Healthy Subjects (NCT01486888) | Novo Nordisk A/S | 2006-05-01 |
| To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together (NCT00318461) | Novo Nordisk A/S | 2006-05-01 |
| Urinary Vitamin C Loss in Diabetic Subjects (NCT00071526) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2006-04-11 |
| A Study of Saxagliptin in Subjects With Type 2 Diabetes Who Have Inadequate Blood Sugar Control With Sulfonylureas (NCT00313313) | AstraZeneca | 2006-04-01 |
| Nutrition, Diabetes and Pulmonary TB/HIV (NCT00311298) | University of Copenhagen | 2006-04-01 |
| The Effect of Exercise on Blood Glucose Levels in Patients With Type 1 Diabetes: A Comparison of 3 Long-acting Insulins (NCT00313742) | Novo Nordisk A/S | 2006-04-01 |
| Vascular Risk After Kidney Transplantation (NCT00374595) | University of Nebraska | 2006-04-01 |
| Comparison of the Leuven Protocol With the Glucommander for Postoperative Control of Blood Glucose With IV Insulin (NCT00795015) | Rush University Medical Center | 2006-04-01 |
| Study of a Home Delivered Meal Program on Obese Elderly African American Subjects With Type 2 Diabetes Mellitus (DM) (NCT00743756) | Emory University | 2006-04-01 |
| Novel Therapies for Metabolic Complications of Lipodystrophies (NCT00457938) | University of Texas Southwestern Medical Center | 2006-04-01 |
| Laparoscopic Roux-en-Y Gastric Bypass Versus Laparoscopic Biliopancreatic Diversion (BPD)- Duodenal Switch for Superobesity (NCT00327912) | Göteborg University | 2006-04-01 |
| Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea. (NCT00313001) | Novo Nordisk A/S | 2006-04-01 |
| Comparison of the Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30, 50, 70 and Insulin Aspart in Subjects With Type 1 Diabetes (NCT01536028) | Novo Nordisk A/S | 2006-04-01 |
| Efficacy and Safety of Three Times a Day BIAsp-70 Compared to Two Times a Day BIAsp-30 in Subjects With Type 2 Diabetes (NCT00318786) | Novo Nordisk A/S | 2006-04-01 |
| Comparison of Two Liraglutide Formulations in Healthy Subjects (NCT01515579) | Novo Nordisk A/S | 2006-04-01 |
| Nutrition and Exercise Intervention Study (NCT00926744) | National Institute of Health and Nutrition | 2006-04-01 |
| Evaluation of DermStream(tm) - an Irrigation Product for Chronic Wound Management (NCT00310752) | EnzySurge | 2006-03-01 |
| Improving Metabolism With HDL Cholesterol (NCT00395148) | Bayside Health | 2006-03-01 |
| Improving Care for Patients With Diabetes and Poor Numeracy Skills (NCT00311922) | Vanderbilt University | 2006-03-01 |
| Safety of Liraglutide in Subjects With Liver Impairment and in Subjects With Normal Liver Function (NCT01507389) | Novo Nordisk A/S | 2006-03-01 |
| An Observational Study in Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes Mellitus (NCT01542424) | Novo Nordisk A/S | 2006-03-01 |
| Bioequivalence of Two Insulin Aspart Formulations (100 U/mL Versus 200 U/mL) (NCT01530048) | Novo Nordisk A/S | 2006-03-01 |
| Neuroendocrine Brake for Type 2 Diabetes Mellitus (NCT00450710) | Medtronic - MITG | 2006-03-01 |
| A Comparison of Insoles Used to Prevent Neuropathic Diabetic Foot Ulceration (NCT00999635) | University of Plymouth | 2006-03-01 |
| Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment (NCT01548235) | Novo Nordisk A/S | 2006-02-01 |
| To Evaluate the Effect of Liraglutide Versus Glimepiride (Amaryl®) on Haemoglobin A1c (NCT00294723) | Novo Nordisk A/S | 2006-02-01 |
| Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes (NCT00282451) | Novo Nordisk A/S | 2006-02-01 |
| Evaluation of Glucose Monitoring Methods: Characterizing Glycemic Control in Subjects With Diabetes (NCT00805506) | HealthPartners Institute | 2006-02-01 |
| Self-Efficacy Enhancing Interviewing Techniques Study (NCT00643435) | University of California, Davis | 2006-02-01 |
| Surgical Intervention for Morbidly Obese Adolescents (NCT00289705) | Göteborg University | 2006-02-01 |
| PACE-iDP: An Intervention for Youth at Risk for Diabetes (NCT00412165) | University of California, San Diego | 2006-02-01 |
| Physiological Concept of Insulin Therapy in Subjects With Type 2 Diabetes (NCT01536639) | Novo Nordisk A/S | 2006-01-01 |
| Effects of Pulsatile Intravenous (IV) Insulin on Wound Healing in Diabetics (NCT00967837) | Florida Atlantic University | 2006-01-01 |
| Intensive Insulin Therapy in Non-diabetic Patients With Acute Myocardial Infarction and Hyperglycaemia (NCT00362778) | Hospital Clinic of Barcelona | 2006-01-01 |
| Pharmacy Interventions to Improve Chronic Disease Medication Refill (NCT00469365) | Medical University of South Carolina | 2006-01-01 |
| The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes (NCT00360217) | Maine Center for Lipids and Cardiovascular Health | 2006-01-01 |
| Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers (NCT01515592) | Novo Nordisk A/S | 2006-01-01 |
| Safety and Efficacy Study of an Interactive Wound Dressing (KC002) for the Treatment of Diabetic Foot Ulcers (NCT00330265) | KeraCure | 2006-01-01 |
| Develop Novel Methods to Display, Report and Analyze CGM Data for Clinical Decision-Making in People With Diabetes (NCT00465881) | HealthPartners Institute | 2006-01-01 |
| Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes (NCT01486875) | Novo Nordisk A/S | 2006-01-01 |
| The Study of HIV Protease Inhibitors and Their Effects on Glucose Metabolism (NCT00259727) | US Department of Veterans Affairs | 2006-01-01 |
| Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients (NCT00658463) | Centre Hospitalier Universitaire Dijon | 2006-01-01 |
| Prandial Orientated Biphasic Insulin Aspart 30 Therapy - the Physiological Premix Insulin Therapy for Type 2 Diabetes (NCT01536652) | Novo Nordisk A/S | 2006-01-01 |
| The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control (NCT00282659) | Hartford Hospital | 2006-01-01 |
| The Effect of Renin Angiotensin System Blockage (RAS) Blockade On PTX3 Levels In Diabetic Patients With Proteinuria (NCT00674596) | Gulhane School of Medicine | 2006-01-01 |
| Improving Diabetes Outcomes: a Couples Intervention (NCT00250731) | State University of New York - Upstate Medical University | 2006-01-01 |
| Efficacy and Safety of Levemir® Used as Basal Insulin (NCT01548248) | Novo Nordisk A/S | 2006-01-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Explorative Formulation of Insulin Degludec (NCT01865279) | Novo Nordisk A/S | 2005-12-01 |
| Self-care Behaviour Treatment in Patients With Diabetes - a Randomised Controlled Trial (NCT00555854) | Odense University Hospital | 2005-12-01 |
| Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes (NCT00267683) | Novo Nordisk A/S | 2005-12-01 |
| Exploring Folk Health Practices in Latinos With Chronic Medical Conditions (NCT00224237) | Weill Medical College of Cornell University | 2005-12-01 |
| The Effects of Natural Versus Man-Made Trans Fatty Acids on Lipoprotein Profiles: A Pilot Study (NCT00535886) | UCSF Benioff Children's Hospital Oakland | 2005-11-01 |
| Effect of Liraglutide Compared to Glimepiride on Appetite in Subjects With Type 2 Diabetes (NCT01511692) | Novo Nordisk A/S | 2005-11-01 |
| Vastmanland Myocardial Infarction Study (VaMIS) (NCT01452178) | Uppsala University | 2005-11-01 |
| Comparison of Two Insulin Detemir Formulations in Healthy Volunteers (NCT01498926) | Novo Nordisk A/S | 2005-11-01 |
| Hyperglycemia in the Intensive Care Unit, a Prevalence Study (NCT00854347) | Université de Montréal | 2005-11-01 |
| Effect of Coccinia Cordifolia Extract on Blood Sugar of Newly Diagnosed Diabetics (NCT00502008) | St. John's Research Institute | 2005-11-01 |
| Changes in Inflammatory State in Asian Americans Changing From Traditional Asian Diets to American Diet - a Pilot Study (NCT00379548) | Joslin Diabetes Center | 2005-11-01 |
| Repaglinide for Adolescents With Cystic Fibrosis-Related Diabetes (NCT00231192) | Children's Hospital of Philadelphia | 2005-10-01 |
| Impact of Diabetes and Glucose Control During Rehabilitation After Stroke (NCT00241956) | Melbourne Health | 2005-10-01 |
| Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs (NCT01486862) | Novo Nordisk A/S | 2005-10-01 |
| Phase 1 Study of Anti-glycation Agent GLY-230 in Healthy Subjects (NCT00544921) | Glycadia | 2005-10-01 |
| Renal and Hormonal Effects of Pioglitazone (NCT01090752) | University Hospital, Geneva | 2005-10-01 |
| Ability of a Tea Leaf Extracts Preparation to Slow Down Carbohydrate and Fat Absorption (NCT00262145) | NatureGen | 2005-10-01 |
| Healthy Lifestyles for Mentally Ill People Who Have Experienced Weight Gain From Their Antipsychotic Medications (NCT00344500) | VA Office of Research and Development | 2005-10-01 |
| Effect of Exercise on the Absorption of Inhaled Human Insulin in Subjects With Type 1 Diabetes (NCT00419718) | Novo Nordisk A/S | 2005-10-01 |
| Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes (NCT00264901) | Novo Nordisk A/S | 2005-10-01 |
| Perioperative Insulin Glargine Dosing Study (NCT00309465) | Tamra Dukatz | 2005-10-01 |
| The Diabetes Telemonitoring (DiaTel) Study (NCT00245882) | United States Department of Defense | 2005-10-01 |
| Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus (NCT01709929) | Novo Nordisk A/S | 2005-10-01 |
| FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers (NCT00425178) | Venturis Therapeutics, Inc. | 2005-09-02 |
| The DINE Study-Diet Intervention to Negate Diabetes Study (Improving Weight Loss Outcomes for African Americans) (NCT00599040) | University of Alabama at Birmingham | 2005-09-01 |
| Insulin Treatment Variation in Southwestern Diabetics (NCT00148304) | VA Office of Research and Development | 2005-09-01 |
| Survey of Thai-Muslim Health Status (NCT00701454) | Mahidol University | 2005-09-01 |
| Efficacy and Safety of a Fixed or a Flexible Supplementary Insulin Therapy in Type 2 Diabetes (NCT00274274) | Novo Nordisk A/S | 2005-09-01 |
| Doctor-Patient Communication in Spanish (NCT00187785) | University of California, San Francisco | 2005-09-01 |
| Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs (NCT00491725) | Novo Nordisk A/S | 2005-09-01 |
| Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes (NCT00394407) | Emory University | 2005-09-01 |